Target Name: MIR4255
NCBI ID: G100422898
Review Report on MIR4255 Target / Biomarker Content of Review Report on MIR4255 Target / Biomarker
MIR4255
Other Name(s): hsa-mir-4255 | microRNA 4255 | hsa-miR-4255 | MicroRNA 4255

MIR4255: A Drug Target / Disease Biomarker

MIR4255 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes a family of transmembrane proteins that are involved in a variety of cellular processes. One of the most interesting aspects of MIR4255 is its potential as a drug target or biomarker.

MIR4255 is known for its role in the regulation of pain signaling. It is expressed in the endothelial cells of the brain, which are responsible for maintaining the blood supply to the brain. When the brain is exposed to pain, MIR4255 is involved in the production of a neurotransmitter called nitric oxide, which helps to relax the blood vessels and increase blood flow to the brain. This increase in blood flow is important for delivering oxygen and nutrients to the brain, which is essential for maintaining its health and function.

In addition to its role in pain signaling, MIR4255 is also involved in the regulation of inflammation. It is expressed in the immune cells of the body, including T cells and macrophages. When the body is exposed to an infection or inflammation, MIR4255 is involved in the production of a protein called IL-6, which is important for the recruitment of immune cells to the site of inflammation.

MIR4255 is also involved in the regulation of cell growth and differentiation. It is expressed in the epithelial cells of the body, which are responsible for forming the lining of various body surfaces and organs. When these cells are dividing, MIR4255 is involved in the regulation of the cell cycle, which is the process by which cells grow and divide.

In addition to its roles in pain signaling, inflammation, and cell growth and differentiation, MIR4255 is also involved in the regulation of stem cell biology. It is expressed in the stem cells of the body, which are responsible for the development and maintenance of tissues and organs. When these cells are differentiated, MIR4255 is involved in the regulation of the cell lineage.

MIR4255 is also a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, some studies have suggested that MIR4255 may be a potential therapeutic target for cancer, due to its involvement in the regulation of cell growth and differentiation. In addition, MIR4255 has also been shown to be involved in the regulation of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In conclusion, MIR4255 is a protein that is expressed in various tissues of the body, with roles in pain signaling, inflammation, cell growth and differentiation, and stem cell biology. Its potential as a drug target or biomarker makes it an attractive target for further research and development. Further studies are needed to fully understand the role of MIR4255 in these processes and to determine its potential as a therapeutic agent.

Protein Name: MicroRNA 4255

The "MIR4255 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4255 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1